---

GlaxoSmithKline (“GSK”) is suing Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK’s patents on mRNA technology in their covid injections.

As reported by Reuters, GSK alleges in the lawsuit filed on Thursday that Pfizer-BioNTech’s Comirnaty injections infringe on GSK’s mRNA vaccine patents developed more than a decade before Pfizer began marketing its “vaccine.”

A Pfizer spokesperson said in a statement that the company is “confident in our [intellectual property] IP position around Comirnaty.”

A GSK spokesperson said the company believes its patents “provided the foundational technology used in Pfizer and BioNTech’s covid-19 mRNA vaccines.”

London-based GSK asked the court for an unspecified amount of monetary damages from Pfizer and BioNTech that includes an ongoing patent licencing fee.

The lawsuit adds to a web of high-stakes US court cases involving Pfizer, BioNTech and Moderna over patent royalties for technology used in their vaccines, including a case brought by Moderna against Pfizer in 2022.

(Related: There’s A Hot Mess Over Patents for Covid Injections and They’re All Suing Each Other)

Almost three years ago, Karen Kingston pointed out that Pfizer was not immune to lawsuits based on intellectual property rights.  She has been proved right.  In the following, Kingston briefly lists other lawsuits that have been filed against Pfizer.

GSK is Suing Pfizer

By Karen Kingston

GlaxoSmithKline (“GSK”) is suing Pfizer for patent infringement. Per Reuters: “GSK said in the lawsuit that Pfizer and BioNTech’s Comirnaty vaccines violate the company’s patent rights in mRNA-vaccine innovations developed ‘more than a decade before’ the outbreak of the covid-19 pandemic.”

Reuters states that “a GSK spokesperson said the company believes its patents ‘provided the foundational technology used in Pfizer and BioNTech’s covid-19 mRNA vaccines’, and that it is ‘willing to license these patents on commercially reasonable terms and to ensure continued patient access’ to the shots.”

Pfizer Thought They Had Immunity Under the PREP Act

On 3 July 2021, I gave my first presentation on the mRNA injections at Doug Billings’ ‘Determined Patriots’ conference in Branson, Missouri. I did a deep dive on Pfizer’s Phase-3 FDA data, Moderna/NIH patents, and a brief overview of the mRNA/Pfizer “vaccine” patent landscape (from an article published in Nature).

To the right of the image are my IP notes from 3 July 2021. Note the NIH/China collaboration on “bat coronaviruses” using the HIV virus beginning in 2004.

On 3 July 2021, I predicted that Pfizer and Moderna would be delusional in believing that they had iron-clad immunity from all lawsuits, and well … these mRNA giants have not disappointed in having monstrous lawsuits brought against them both.

Brief Update on Pfizer and mRNA Lawsuits and Settlements

In 2021, Pfizer settled a lawsuit with Allele for mNeonGreen used in the manufacturing of Pfizer’s mRNA injections BNT162b2.

The US National Institutes of Health (“NIH”) and university scientists sued Moderna for their use of the patented “spike protein” and won $400 million.

Moderna brought a lawsuit against Pfizer in 2022, which has been put on pause due to the US Patent Office’s upcoming ruling on the validity of Moderna’s mRNA patents.

Texas is suing the pants off of Pfizer, bringing 18 counts against the pharma giant under the Texas Deceptive Trade Practices Act.

Dr. Joe Sansone is in the process of appealing a Florida District Judge’s recent dismissal of the writ mandamus filed to have Governor DeSantis and Attorney General Ashley Moody ban the covid-19 mRNA injections from the state of Florida.

Brook Jackson’s whistleblower case against Pfizer for committing mass fraud against the US people in conducting their Phase 3 clinical trials, has a 1 May 2024 hearing scheduled for her attorneys to argue against the judge’s recent motion to dismiss and to continue the hearing.

Go get ‘em, Brook! You can follow this courageous woman HERE.

About the Author

Karen Kingston is an American biotech analyst and medical-legal advisor.  She regularly publishes articles on a Substack page titled ‘The Kingston Report’ which you can subscribe to and follow HERE.

Featured image: Emma Walmsley, GSK CEO (left).  Albert Bourla, Pfizer CEO (right). Source: Karen Kingston